@article{9483a993e5064e268d8cd5d94571f72e,
title = "Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a Β-galactosidase-activatable prodrug seco-analog of duocarmycin SA",
keywords = "breast cancer, oncolytic virotherapy, prodrug, vaccinia virus",
author = "Seubert, \{C. M.\} and J. Stritzker and M. Hess and U. Donat and Sturm, \{J. B.\} and N. Chen and Hof, \{J. M.V.\} and B. Krewer and Tietze, \{L. F.\} and I. Gentschev and Szalay, \{A. A.\}",
note = "Funding Information: The authors thank Terry Trevino, Jason Aguilar and Johanna Langbein for excellent technical assistance, Marion Adelfinger for animal care, Birgit Bergmann and Linda B{\"o}hme for antibodies, Detlev Schindler and Richard Friedel for support on flow cytometry and Andrea Feathers and Dana Haddad for editorial help. BK thanks the Deutsche Telekom Foundation for a PhD scholarship. The research was supported by Genelux Corporation, San Diego, USA.",
year = "2011",
month = jan,
doi = "10.1038/cgt.2010.49",
language = "English",
volume = "18",
pages = "42--52",
journal = "Cancer Gene Therapy",
issn = "0929-1903",
number = "1",
}